A Controlled Trial of Abreaction with Lysergic Acid Diethylamide (Lsd-25)
The British Journal of Psychiatry January 1, 1963 J. Robinson, Lyndon Davies, E. L. N. S. Sack et al. 18 citations
Lysergic acid diethylamide (LSD-25) is described as a valuable aid to psychotherapy, acting as a deep abreactive agent that can erupt early traumatic experiences from infancy, accompanied by emotional catharsis believed to provide therapeutic benefit. It is also claimed to facilitate and enhance the transference situation between patient and therapist.